Between 2009 and 2013, over 70 people living with MND (and some healthy people of similar age for comparison), took part in a new type of patient-based study. Men and women of all ages (from 28 to 86), some with primary lateral sclerosis (PLS) as well as a range of the more common amyotrophic lateral sclerosis (ALS) types, all gave up their time to attend for a day or two of tests in Oxford.
Martin Turner writes blog on diagnosing MND earlier
- 11 June 2014
- Clinical Neurology
The Motor Neuron Disease Association has published a blog post from Martin Turner about 'BioMOx', the Oxford Study for Biomarkers in MND.